NeuroMetrix says the FDA granted 510(k) clearance for over-the-counter sales of its wearable chronic pain device.
Jorge Quinoy, president of Volcano Corp.'s U.S. & APLAC commercial sales, is leaving the company effective today.
Volcano (NSDQ:VOLC) said last week that its president for U.S. & APLAC commercial sales, Jorge (George) Quinoy, is leaving the company effective today.
Omron healthcare will distribute in Japan.
NeuroMetrix's shares jump nearly 20% after the company lands Japanese marketing approval for its NC-stat DPNCheck for detecting diabetic peripheral neuropathy.
NeuroMetrix (NSDQ:NURO) got a major Wall Street boost today after announcing Japanese market approval for its NC-stat DPNCheck test for diabetic peripheral neuropathy.
Hedge fund giant BlackRock boosted its stake in a number of medical device companies last year, but cut its holdings in others, regulatory filings show.
Wright Medical Group Inc.
, Align Technology Inc.
, ArthroCare Corp.
, AtriCure Inc.
, Biolase Technology Inc.
, BlackRock Inc.
, Cutera Inc.
, Cynosure Inc.
, Dentsply International Inc.
, HeartWare International Inc.
, ICU Medical Inc.
, Medical Action Industries Inc.
, Merit Medical Systems Inc.
, NxStage Medical Inc.
, Thoratec Corp.
DJO Global inks a deal to distribute the NeuroMetrix Sensus pain management device in the U.S.
NeuroMetrix (NSDQ:NURO) said it signed a national distribution deal with DJO Global for its Sensus pain management system.
NeuroMetrix shares gain after it announces a distribution deal in China for its NC-stat DPNCheck diabetic peripheral neuropathy device.
NeuroMetrix (NSDQ:NURO) said it inked a deal with Omron Medical Devices, a subsidiary of Omron Healthcare China, for the distribution rights to NeuroMetrix's NC-stat DPNCheck in China.